A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Abramson Cancer Center at Penn Medicine
City of Hope Medical Center
Stanford University
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Memorial Sloan Kettering Cancer Center
INSYS Therapeutics Inc